SAO Equity Snapshot

B1MR34 Weekly Equity Report

BioMarin Pharmaceutical Inc.

Interactive chart JSON snapshot
Latest Close 142.0 BRL 12 Jun 2026
1W Return 0.0% latest completed week
4W Return 7.6% short-term follow-through
12W Return -9.5% quarterly tape
Trend Breadth 15.4% 8 of 52 weeks active
Volume Ratio - vs 13-week average
Company Brief

What the company does

BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally. The company's products include VIMIZIM, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; VOXZOGO, a once daily injection analog of c-type natriuretic peptide (CNP) for the treatment of achondroplasia; NAGLAZYME, a recombinant form of N- acetylgalactosamine 4-sulfatase for patients with MPS VI; and PALYNZIQ, a PEGylated recombinant phenylalanine (Phe) ammonia …

Snapshot

What the weekly tape is saying

B1MR34 closed the latest completed week at 142.0 BRL. The 4-week return is 7.6% and the 12-week return is -9.5%. Trend Signal is inactive, Market Dynamics is -0.77. Setup signature: Risk-first tape with a 28/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -5.3%
Volume -
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 8 Persistence of active Trend Signal over the last year and current streak.
Momentum 59 Blend of 4-week and 12-week follow-through.
Dynamics 39 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 16 Relative leadership and short-term RS change.
Volume 0 Participation compared with the 13-week volume baseline.
Risk Control 43 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
149.9 BRL
Vs Trend Line
-5.3%
Fair Value
190.8 BRL
Vs Fair Value
-25.6%
52W High
174.6 BRL
52W Low
123.5 BRL
Drawdown
-18.7%
Range Position
36.2%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 0.0%
4W 7.6%
12W -9.5%
26W -3.3%
52W -11.1%

Trend read

Active Streak
0 weeks
52W Active Weeks
8
52W Active Breadth
15.4%
Sector Scope
BR Healthcare
Sector Rank
41 of 80
Sector Percentile
49.4%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.77
4W MD Change
34.5%
Relative Strength
-12.51
4W RS Change
47.6%
Expectation
Negative
Probability
33.27%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
0
13W Average
234
52W Average
530
Vs 13W
-
Vs 52W
-
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
4.0%
52W Volatility
4.2%
Upside Weeks
17
Downside Weeks
21
Downside Breadth
40.4%
Avg Gain / Loss
3.8% / -3.4%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
SAO
Country
BR
Sector
Healthcare
Industry
Biotechnology
Currency
BRL
Market Cap
54.9B

Opportunity signals

  • No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Market Dynamics is negative, which weakens the current setup.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 142.0 BRL 0.0% 149.9 BRL 190.8 BRL -0.77 -12.51 0 Off
5 Jun 2026 142.0 BRL 7.1% 149.9 BRL 191.4 BRL -0.96 -12.01 200 Off
29 May 2026 132.6 BRL -2.3% 149.8 BRL 192.0 BRL -1.09 -20.63 211 Off
22 May 2026 135.7 BRL 2.8% 150.1 BRL 192.6 BRL -1.08 -20.56 2.0K Off
15 May 2026 132.0 BRL 0.0% 150.4 BRL 193.1 BRL -1.18 -23.87 0 Off
8 May 2026 132.0 BRL -0.7% 150.8 BRL 193.8 BRL -1.18 -27.33 600 Off
1 May 2026 132.8 BRL 0.0% 151.1 BRL 194.5 BRL -1.17 -28.84 0 Off
24 Apr 2026 132.8 BRL -4.8% 151.4 BRL 195.1 BRL -0.97 -30.88 1 Off
17 Apr 2026 139.5 BRL 0.0% 151.7 BRL 195.8 BRL -0.77 -30.13 0 Off
10 Apr 2026 139.5 BRL -11.1% 151.8 BRL 196.5 BRL -0.52 -31.85 20 Off
3 Apr 2026 156.9 BRL 0.0% 152.1 BRL 197.1 BRL -0.24 -20.90 0 On
27 Mar 2026 156.9 BRL 0.0% 152.3 BRL 197.7 BRL -0.10 -19.25 0 On
20 Mar 2026 156.9 BRL 0.0% 152.3 BRL 198.3 BRL 0.22 -17.87 0 On
13 Mar 2026 156.9 BRL -2.0% 152.3 BRL 198.9 BRL 0.45 -19.41 401 On